Market on Radiation Therapy system - Research Paper Example

Accuray’s commercial release of installed base systems has increased from zero to approximately 600 systems in a decade. These sales have been recorded mainly in the United States and internationally. The high release is as a result of the growing demand for efficient and effective radiation therapy in the market. The development of clinical evidence that support the merits of IMRT and image-guided radiotherapy is also a boost to this technology (Faiz 140). Manufacturers of Radiation Therapy systems Accuray in the third quarter of fiscal 2013 recorded an increase in new orders.

The corporation has also installed TomoTherapy H series and the new Cyber-knife M6 series systems. These installations have led to an increase in the gross profit and an improvement in service revenue. A gross total of $53.8 million of new product orders have been recorded in the third quarter of fiscal 2013. The second quarter of fiscal 2013 had a gross product orders totaling to $39.8 million. The net product orders in the third quarter of fiscal 2013 amounted to $44.1 million as compared to the previous quarter with $17.9 million. The company has also recorded ending product backlog of $279.

9 million marking a 7% increase from the previous quarter. . Varian company attained net orders worth $3,122 million and recorded a total of $2,807 million revenue last year. These records show an increase in net orders from $2,933 and an increase in revenue from $2,597 in the previous year. The operating earnings of the company in the fiscal 2011 totaled $588 million which increased to $594 million in fiscal 2012. Net earnings in fiscal 2012 were $427 million from $409 million in the previous year.

Elekta Oncology Systems Inc. manufactures integrated x-ray systems, linear accelerators with multileaf collimators and offers clinical solutions for patient fixation and positioning (Arno and Roeske 100). It supplies its products to cancer centers, universities and hospitals. The corporation is famous for introducing critical technological advances in the radiotherapy field. The company focuses on evidence-based medicine with the aim of saving and prolonging life. Some of the techniques used by Elekta are Stereotactic radiation therapy, Image Guided Radiotherapy, beam shaping and motion management (David et al 730).

The company expects the net sales of the fiscal year 2012/1013 to increase by 15% in local currency. It expects an increase of operating profit by over 15% despite effects of exchange rates volatility. The company recorded a total of$1.46 billion and a net income of $0.16 billion. Costs Radiation Therapy systems X-ray radiation therapy system costs about $10 million and requires less space as compared to particle beam therapies whose facility cost up to $100 million. Varian Inc. holds approximately 60% of the international market share of radiation oncology equipment.

A brand new system costs $2-3